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CONSENSUS

A multi‑institution consensus on how to perform
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ABSTRACT
Background and Objectives: EUS‑guided biliary drainage (EUS‑BD) was shown to be useful for malignant biliary
obstruction (MBO). However, there is lack of consensus on how EUS‑BD should be performed. Methods: This was
a worldwide multi‑institutional survey among members of the International Society of EUS conducted in February
2018. The survey consisted of 10 questions related to the practice of EUS‑BD. Results: Forty‑six endoscopists of
them completed the survey. The majority of endoscopists felt that EUS‑BD could replace percutaneous transhepatic
biliary drainage after failure of ERCP. Among all EUS‑BD methods, the rendezvous stenting technique should be
the first choice. Self‑expandable metal stents (SEMSs) were recommended by most endoscopists. For EUS‑guided
hepaticogastrostomy (HGS), superiority of partially‑covered SEMS over fully‑covered SEMS was not in agreement.
6‑Fr cystotomes were recommended for fistula creation. During the HGS approach, longer SEMS (8 or 10 cm)
was recommended. During the choledochoduodenostomy approach, 6‑cm SEMS was recommended. During the
intrahepatic (IH) approach, the IH segment 3 was recommended. Conclusion: This is the first worldwide survey on
the practice of EUS‑BD for MBO. There were wide variations in practice, and randomized studies are urgently needed
to establish the best approach for the management of this condition.
Key words: Consensus, EUS‑guided biliary drainage, questionnaire survey

INTRODUCTION
Palliative endoscopic biliary stenting is routinely
performed in patients with nonresectable, distal,
malignant biliar y strictures. The endoscopic
transpapillary approach based on the ERCP technique
is an established treatment for nonsurgical relief of
malignant biliary obstruction (MBO). [1] However,
ERCP is not always successful even when performed
by skilled endoscopists. Several underlying reasons
include the presence of intradiverticular papillae,
long narrow distal segment of the distal bile duct,
altered anatomy, and gastroduodenal obstruction. [2]
When ERCP fails, percutaneous transhepatic biliary
drainage (PTBD) or surgical bypass procedures are
performed as salvage therapies.[3] Percutaneous access
and surgical options are associated with morbidity,
mortality, expense, and requirement of substantial
expertise.[4]
The EUS‑guided biliary drainage (EUS‑BD)
was
first
demonstrated
by
Wiersema
et al.[5] in 1996. Subsequently, various improvizations

for EUS-BD techniques occurred such as EUSguided choledochoduodenostomy (EUS-CDS),
hepaticogastrostomy (HGS), antegrade stenting (AGS),
and rendezvous procedure (RV). These tichiques all
have recently been shown to be useful for biliary
drainage after unsuccessful ERCP.[6]
Since no international guidelines or consensus for
the EUS‑BD exist, the formulation of questions
used was based on the opinions of regional experts
regarding what constitutes the most important aspects
or controversial areas of EUS‑BD, e.g., which method
of EUS‑BD should be preferred based on the site
of biliary obstruction? How should EUS‑BD be
performed? To this end, a consensus among leading
experts on EUS‑BD based on a survey of EUS‑BD
techniques would be helpful in understanding practice
patterns worldwide.
METHODS
A 10‑question survey regarding the practice of EUS‑BD
was circulated among members of the International
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Society of EUS in February 2018. Before completing
the survey, participants were reminded that the questions
listed were only directed toward EUS‑BD. The responses
to the questions were reported anonymously.

Design of the questionnaire

The questions contained within the questionnaire were
grouped under several sections, including which method is
better, the type of stent used for drainage, the length of
stent, and endoscopic tools utilized for creating a fistula,
among other categories. Statements were formulated by
combining a formal literature review of the endoscopic
treatment of MBO with expert opinions from the
members of the International Society of EUS. The
quality of evidence and classification of recommendation
categories for the questionnaire are shown in Table 1.
RESULTS

Question 1

EUS‑BD is increasingly used as an alternate
therapeutic modality to PTBD for biliary obstruction
in patients who fail ERCP. Can EUS‑BD
replace PTBD as a remedy method after failure of ERCP?
A. Yes, EUS‑BD is the first choice after failure of ERCP
B. No, PTBD is the first choice after failure of ERCP
C. Other (please specify).
Table 1. Quality of evidence, classification of
recommendations of the questionnaire
Category and grade Description
Quality of evidence
I
II‑1
II‑2
II‑3

III
Classification of the
recommendation
A
B
C

D
E

Evidence obtained from at least one RCT
Evidence obtained from well‑designed
control trials without randomization
Evidence obtained from a well‑designed
cohort or case–control study
Evidence obtained from comparisons
between times or places with
or without intervention
Opinion of respected authorities based on
clinical experience and expert committees

There is good evidence to
support the statement
There is fair evidence to
support the statement
There is poor evidence to support the
statement, but the recommendation
was made on other grounds
There is fair evidence to
refute the statement
There is good evidence to refute the
statement

RCT: Randomized controlled trial
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Answer

The majority of endoscopists (73.08% [38/52]) felt
that EUS‑BD may replace PTBD as a drainage
method after failure of ERCP, 17.31% (9/52) of the
endoscopists felt that PTBD is still the first choice,
and 9.62% (5/52) of the endoscopists did not have
any preference. Some of them believed that the
better choice depends on the center of excellence and
professionalism of the available operator. In addition,
a few of them believed that EUS‑BD and PTBD are
equal and the choice depends on individual situations.
Regarding the PTBD status, what is a better alternative
method (PTBD or EUS‑BD) for patients after
failure of ERCP? In recent years, EUS‑BD has been
increasingly applied in MBO therapy, with gradual
appreciation of its advantages. Compared with PTBD,
the most prominent advantage of EUS‑BD is that it
will not cause electrolyte imbalance due to external bile
drainage.[7] There are some well‑designed control trials
supporting this point.
Sharaiha et al. [7] reviewed nine studies that included
483 patients in total. There was no difference
in technical success between the two procedures
(EUS‑BD and PTBD), but EUS‑BD was associated
with better clinical success, fewer postprocedure adverse
events (AEs), and lower rate of reintervention. When
ERCP fails to achieve biliary drainage, EUS‑guided
interventions may be preferred over PTBD if adequate
advanced endoscopy expertise and logistics are available.
Khashab et al. [8] evaluated 73 jaundice patients with
distal MBO who either underwent EUS‑BD (n = 22) or
PTBD (n = 51) after failure of ERCP. Technical success,
clinical success, and AEs between the two groups were
compared. Although technical success rate (TSR) was
higher in the PTBD group (100 vs. 86.4%, P = 0.007),
clinical success rate was equivalent (92.2 vs. 86.4%,
P = 0.40). PTBD was associated with a higher AE
rate (index procedure: 39.2 vs. 18.2%; all procedures
including reinterventions: 80.4 vs. 15.7%). EUS‑BD and
PTBD were found to be comparably effective techniques
for the treatment of distal MBO after failure of ERCP.
However, EUS‑BD was associated with a reduced AEs
rate and is significantly less expensive due to the need for
fewer reinterventions.
An international multicenter survey was conducted in
seven tertiary referral centers about patient perception
and preference of EUS‑BD and PTBD. [9] Three
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hundred and twenty‑seven patients with suspected MBO
were enrolled in the study. Patients were questioned
regarding their choice between EUS‑BD and PTBD
after failure of ERCP, the reasons for their preference,
and whether altering AE rates would influence their
prior choice. In total, 313 patients (95.7%) responded to
the questionnaire and 251 (80.2%) preferred EUS‑BD.
The main reason for choosing EUS‑BD was the
possibility of internal drainage (78.1%).
Of course, if inter ventional radiologists or
gastroenterologists with adequate experience on
ultrasound‑guided percutaneous techniques were invited
to take part in this survey, the preference for EUS‑BD
vs. PTBD may have been lower.[10]
Quality of evidence: II‑1.
Classification of recommendation: B.

Question 2

In a potential clinical situation, which EUS‑BD
technique should be the first choice for MBO:
Rendezvous stenting (RV), EUS‑AGS, or
EUS‑HGS/CDS?
A. RV
B. EUS‑AGS
C. EUS‑HGS
D. EUS‑CDS
E. Anything else.

Answer

In the comparison of EUS‑BD methods, 31.91% (15/47)
endoscopists felt that RV should be the first choice for
MBO, while 29.79% (14/47) felt that EUS‑CDS should
be the first choice; 23.40% (11/47) endoscopists had
no specific preference. A few of them believed that it
depends on several factors, in particular (a) anatomy of
the upper gastrointestinal (GI) tract and possible access
route; (b) localization of the biliary obstruction; (c)
presence of ascites yes/no; in most cases, the rendezvous
or antegrade technique would still be the first choice. In
addition, 10.64% (5/47) of the endoscopists felt that
the EUS‑guided antegrade technique should be the first
choice, and 4.26% (2/47) felt that EUS‑HGS should be
the first choice.
EUS‑BD is an emerging alternative to PTBD or surgery
after failure of ERCP.[11‑13] EUS‑BD can be performed in
three ways: EUS‑HGS, CDS, and RV therapy.[12,14‑21] Once
a decision to perform EUS‑BD has been made, the next

step is to determine which biliary approach should be
selected. At present, there are no optimal answers such
as practical guidelines regarding the selection of EUS‑BD.
Thus far, the selection of the EUS‑BD approach
depends on the patient’s condition, which may involve
the presence of gastric outlet obstruction, site of biliary
obstruction, Roux‑en‑Y anastomosis, or preference
of endoscopists. [22] EUS‑RV seems to be the safest
of all three approaches.[23] Most experts agree that, if
conditions permit, the duodenal papilla represents the
most reasonable route. There are some well‑designed
control trials supporting this point.
In the study by Iwashita et al.,[24] a total of 40 patients
underwent salvage EUS‑RV immediately after failure of
biliary cannulation. A dilated intra‑ or extra‑hepatic biliary
duct (IHBD or EHBD) was punctured from the stomach
or small intestine under EUS guidance followed by
cholangiography and antegrade manipulation of the guide
wire into the small intestine. Antegrade manipulation
of the guide wire into the small intestine was achieved
in 29 of 40 patients (73 %; EHBD 25 /31 and IHBD
4/9). Complications occurred in five patients (13%) and
included pancreatitis, abdominal pain, pneumoperitoneum,
and sepsis/death, which were believed to be unrelated to
the procedure. The conclusion of their study was that
EUS‑RV is safe and effective and should be considered
as a primary salvage technique after failure of cannulation.
In the study by Holt et al., [25] a total of 524 native
papilla ERCPs were performed. Cannulation was
unsuccessful in 0.6% (3/518) of cases when ampulla
was accessible. EUS‑BD was indicated in 0.6% (3/524)
of all referred native papilla ERCPs. EUS‑BD was
successful in all cases. The choice and sequence of
biliary devices, cannulation method, and postprocedural
management were at the endoscopists’ discretion. As
per the departmental protocol, all patients with failure
of ERCP were assessed for EUS‑BD [Figure 1].
In EUS‑guided biliary interventions, the access and
drainage routes should be chosen depending on the
indication, level of the biliary obstruction, anatomical
condition of the upper GI tract, and operator’s
experience. [26] EUS‑RV may not be possible in all
cases with impossible endoscopic access to papilla or
hepaticojejunostomy.
In the study by Tyberg et al.,[27] a new algorithm was
presented. Patients with a dilated IH biliary tree (IHBT)

ENDOSCOPIC ULTRASOUND / VOLUME 7 | ISSUE 6 / NOVEMBER-DECEMBER 2018

359

[Downloaded free from http://www.eusjournal.com on Thursday, January 3, 2019, IP: 147.140.233.16]

Guo, et al.: Consensus on how to perform EUS-BD

Figure 1. EUS‑guided biliary drainage algorithm after failed ERCP for
malignant obstruction

on cross‑sectional imaging received treatment with an
IH approach with anterograde biliary stent placement,
or HGS stent placement if anterograde placement
was not feasible. Patients with a nondilated IHBT on
cross‑sectional imaging underwent treatment with an
extrahepatic (EH) approach with an RV technique, or
transenteric stent placement if the RV technique was
not feasible. Patients underwent the drainage procedure
according to the novel algorithm. Fifty‑two patients
were included in the registry. Technical success was
achieved in 50 patients (96%). AEs were observed in
five patients.
EUS‑CDS is mainly indicated for patients with distal
MBO in whom ERCP has failed. However, the
feasibility of EUS‑CDS as the first‑line treatment for
distal MBO was recently reported. [28] Some studies
have also focused on comparing the IH and EH
approaches of EUS‑BD. Most studies have shown
that there was no difference between the two
approaches.[29‑31]
Uemura et al. [29] reviewed 10 studies involving
434 patients, of whom 208 underwent biliary drainage
via HGS and the remaining 226 via CDS. The technical
success for CDS and HGS was 94.1% and 93.7%,
respectively. Clinical success was 88.5% in CDS and
84.5% in HGS. There was no difference in AEs. CDS
was approximately 2 min faster than HGS.
In the study by Gupta et al.,[30] EUS‑BD was reviewed
across six international centers. In doing so, the EH
and IH approaches were compared. Two hundred
and forty patients (with a mean age 67.3 years)
underwent EUS‑BD. Success was achieved in 87%
cases, with a similar success rate in EH and IH
approaches (84.3% vs. 90.4%; P = 0.15). No significant
difference was noted between the IH and the EH
approaches (32.6% vs. 35.6%; P = 0.64). Poincloux
360

et al. [31] evaluated 101 patients (malignant = 98,
benign = 3) in whom ERCP previously failed and
who underwent treatment with an IH or EH EUS
approach with transluminal stenting or an EUS‑RV with
transpapillary stent placement. A total of 71 patients
underwent the IH approach, and 30 underwent the EH
approach. TSR and clinical success rates were 98.0% and
92.1%, respectively. There was no difference in efficacy
between HGS and CDS (94% vs. 90%; P = 0.69) or in
major complications (10.6% vs. 6.7%; P = 1).
Larger prospective and multicenter studies are needed
to better define the indications, outcomes, and
complications.
Quality of evidence: II‑1.
Classification of recommendation: B.

Question 3

In a clinical situation, which transhepatic technique do
you usually choose? EUS‑AGS, or EUS‑HGS? In your
opinion, which technique has higher TSR and clinical
success rates?
A. EUS‑AGS
B. EUS‑HGS
C. Anything else.

Answer

In the transhepatic technique, 51.06% (24/47)
endoscopists preferred EUS‑HGS, while 42.55% (20/47)
endoscopists preferred the EUS‑guided antegrade
technique; 6.38% (3/47) endoscopists did not have a
preference.
Evidence has been obtained from some well‑designed
cohorts. Some experts prefer the IH route which may
be safer for antegrade procedures, with lower risk
of bile leakage compared with the EH approach.[32,33]
The absence of bile leak at the point puncture is due
the liver parenchyma (around the IHBD) tamponading
the temporary fistula.
There was not any clinical studies compared the
technical and clinical success between AGS and HGS.
Weilert et al.[34] assessed 21 consecutive patients who
underwent EUS‑BD drainage for failed ERCP. Technical
success was achieved in 20/21 (95.2%) patients,
while clinical success was achieved in 19/21 (90.4%).
Anterograde inter ventions were perfor med in
16/20 (80%), while 3/20 (15%) underwent rendezvous
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and 1/20 (5%) underwent CDS. In their study,
EUS‑guided antegrade biliary drainage using the IH
access route resulted in a high technical and clinical
success rate with a low risk of AEs. Poincloux et al.[31]
studied a total of 71 patients who underwent treatment
with an IH approach (5 EUS‑guided antegrade
technique and 66 EUS‑HGS). Technical and clinical
success was achieved in all patients who underwent the
EUS‑guided antegrade technique, and no procedural
complications were observed. In patients undergoing
EUS‑HGS, the technical success was 98.5% (65/66).
The EUS antegrade technique appears to be a safe
and effective salvage option after failure of ERCP,
but the success rate of drainage is low compared with
EUS‑transluminal BD because of relative complicated
procedure.[35]
EUS‑HGS combined with AGS (EUS‑HGAS) is a
modified HGS technique that is superior to HGS in
terms of the AE rate and stent patency. When stent
dysfunction occurs, reintervention is more difficult
after AGS alone than after HGS or CDS. In a study
by Ogura et al.’s study,[36] EUS‑HGAS was evaluated.
A total of 49 patients were enrolled. The TSR of
EUS‑HGS was 95.8% (47/49). EUS‑AS failed in five
patients because the guide wire could not be advanced
into the intestine across the bile duct obstruction site.
EUS‑HGAS has the clinical benefit of obtaining a long
stent patency and avoiding AEs, such as bile peritonitis.
In a study by Imai et al.,[37] EUS‑HGS and EUS‑HGAS
were compared in terms of TSR, FSR, AE rates,
reintervention rates, patient survival time, and time to
stent dysfunction or patient death. They concluded
that, although the TSR of HGS with AGS was lower
than that of EUS‑HGS, EUS‑HGAS was superior to
EUS‑HGS in terms of AE rate and stent patency.
Quality of evidence: II‑2.
Classification of recommendation: B.

Question 4

Should self‑expandable metal stent (SEMS) become the
standard of care for the creation of EUS‑BD?

Answer

Most endoscopists (87.23%, 41/47) felt that SEMS
should become the standard choice for EUS‑BD;
4.26% (2/47) felt that SEMS should not become the
standard choice; and 8.51% (4/47) endoscopists had no

particular preference. A few of them felt that SEMS is
the first choice in EUS‑CDS and plastic stent (PS) is
the first choice in EUS‑HGS.
Multiple studies have clearly demonstrated the
superiority of the SEMS over plastic stents in
ter ms of long‑ter m patency, complications, and
reinterventions.[38,39] Wang et al.[40] reviewed a total of
42 studies that included 1192 patients. The TSR, FSR,
and AE rates were 94.71%, 91.66%, and 23.32%,
respectively. Metal stents were used in 24 studies
involving 525 patients and plastic stents were used in
five studies involving 58 patients. The FSR of studies
using plastic and mental stents was 98.24% and 94.51%,
respectively. There was no statistical difference between
the two groups (P = 0.343). The AE rate of the
mental stent group was lower than that of the plastic
stent (P = 0.013).
Schmidt et al.[41] performed a randomized, multicenter
study comparing stent patency, and complication
rates between plastic stent and SEMS in patients with
unresectable, malignant, distal, and biliary obstruction.
In their study, the frequency of stent failure was
significantly higher in the plastic stent group compared
with the SEMS group. A high incidence of early stent
failure within 8 weeks was observed in the plastic
group. Thus, the plastic stent may not be appropriate
for mid‑ or long‑term drainage of MBO.
Quality of evidence: I.
Classification of recommendation: A.

Question 5

Which type of SEMS will be better for EUS‑HGS:
Fully‑covered (FC) or partially‑covered (PC)?

Answer

In total, 44.68% (21/47) endoscopists felt that FC
SEMSs are better, while 44.68% (21/47) felt that
half‑covered SEMSs are better, and 8.51% (4/47)
endoscopists did not have a specific preference.
SEMSs are widely used for MBOs. Both FC and PC
SEMS are now commercially available for distal MBO.
While FC SEMS can be easily removed at the time of
reintervention, they are theoretically prone to migration.
There is no consensus on the best stent type for the
management of MBO. Evidence has been obtained
from some well‑designed cohorts.
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In the study by Rai et al.,[42] 6‑cm PC SEMSs were used
in patients undergoing EUS‑CDS. Technical success
was achieved in 28 patients, all of which also exhibited
clinical success. Three patients had AEs (bile leak,
hemobilia, stent block in one patient each; no stent
migration), although none of these AEs were major
and all were managed successfully. EUS‑CDS with a PC
SEMS results in a high technical and clinical success,
whereas a number of AEs were infrequent, minor and
could be easily managed.
In the study by De Cassan et al.,[43] a dedicated biliary
SEMS with a PC SEMS was used to perform EUS‑HGS.
A total of 41 patients were included. Technical
success was achieved in 37 (90.2%) patients. Thirteen
patients (31.7%) presented an early complication, which
was generally an infection. At the 6‑month follow‑up,
10/37 patients (27.0%) required a new biliary drainage
and 11/37 (29.7%) died because of their disease.

has been done to confirm which devices are better.
A Korean study[12] is the only one that showed higher
complications (pneumoperitoneum or bleeding) with
needle knife.
In the survey, 6‑Fr cystotomes were recommended by
most endoscopists.
Quality of evidence: III.
Classification of recommendation: C.

Question 7

Classification of recommendation: B.

During the CDS procedure, what instrument did you
choose to create a fistula if hot AXIOS or other metal
stent with hot delivery was not aviluable?
A. 6‑Fr and 7‑Fr tapered biliary dilator catheters;
B. 6‑Fr cystotomes
C. 8.5‑Fr cystotomes
D. 10‑Fr cystotomes
E. Fistulotome
F. Needle knife
G. Other (please specify).

Question 6

Answer

Quality of evidence: II‑2.

During the transhepatic approach, what instrument did
you choose to create the hepatogastric fistula if hot
AXIOS or other metal stent with hot delivery was not
aviluable?
A. 6‑Fr and 7‑Fr tapered biliary dilator catheters
B. 6‑Fr cystotomes
C. 8.5‑Fr cystotomes
D. 10‑Fr cystotomes
E. Fistulotome
F. Needle knife
G. Other (please specify).

Answer

During the transhepatic approach, 47.83% (22/46)
endoscopists recommended 6‑Fr cystotomes to generate
a hepatogastric fistula, 15.22% (7/46) endoscopists
recommended 6‑Fr and 7‑Fr tapered biliary dilator
catheters, and 15.22% (7/46) endoscopists did not have
a preference. Biliary balloon dilator (4 mm), specific
dilator (7-Fr), and 5–4–3 contour catheter over 0.025”
guidewire were recommended by them.
To create a hepatogastric fistula, different studies have
described the use of different instruments, such as
tapered biliary dilator catheters, different models of
cystotomes, fistulotome, and needle knife. No research
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During the CDS approach, 40.43% (19/47) of
endoscopists recommended 6‑Fr cystotome to make a
fistula, 12.77% (6/46) of endoscopists recommended
6‑Fr and 7‑Fr tapered biliary dilator catheters, and
27.66% (13/46) of endoscopists did not have a specific
preference.
Quality of evidence: III.
Classification of recommendation: C.

Question 8

During the HGS approach, what length of SEMS was
recommended?
A. 4 cm
B. 6 cm
C. 8 cm
D. 10 cm
E. Other (please specify).

Answer

During the HGS approach, 68.09% (32/47) of
endoscopists recommended longer SEMS (8 or 10 cm) .
No research has proven the ideal length of SEMS. In the
survey, we found that most endoscopists recommended
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an 8‑cm or 10‑cm SEMS. This may be because the
distance between the left hepatic duct and the stomach
is longer, thereby necessitating a longer stent. Under such
circumstances, the stent migration rate is relatively low.
Quality of evidence: III.
Classification of recommendation: C.

Question 9

During the CDS procedure, what length of SEMS is
recommended if LAMS is not available?
A. 4 cm
B. 6 cm
C. 8 cm
D. 10 cm
E. Other (please specify).

Answer

During the CDS approach, 50% (23/46) of
endoscopists recommended a 6‑cm SEMS.
Quality of evidence: III.
Classification of recommendation: C.

Question 10

Which IH segment do you usually choose during IH
approach?
A. IH segment 3
B. IH segment 2
C. Other.

Answer

During the IH approach, 59.57% of (28/47) endoscopists
recommended puncture of the IH segment 3.
When selecting the IH bile duct to puncture, a study by
Park[12] recommended dilated bile duct segment 3 (B3)
as the preferred puncture site over B2 for transgastric
stenting. By contrast, a B2 puncture is made in the cardia
or the esophageal gastric junction, whereby it is difficult
to visualize stent deployment under direct endoscopic
imaging. However, puncture to B2 is more feasible than
to B3 for the rendezvous technique because the direction
of the guidewire in B2 is relatively straight and acutely
angled compared with that in B3.[16,44,45]
Quality of evidence: II.
Classification of recommendation: B.

DISCUSSION
In our endoscopy center, EUS‑BD is the first choice
as a drainage method after failure of ERCP. A study
on EUS‑BD using a FC metallic stent after failure
of ERCP at our center showed it to be a safe and
effective method for the treatment of obstructive
jaundice.[46] The TSR and clinical success rates were
both 100%. There was no difference in efficacy
between HGS and CDS. AEs occurred in three patients,
including two in the HGS group (1 bile leakage and
1 sepsis) and one in the CDS group (sepsis).
In clinical situations, EUS‑RV was always chosen to be
a primary salvage technique after failure of cannulation
at our center. The duodenal papilla represents the most
reasonable route. Larger prospective and multicenter
studies are needed to better define the indications,
outcomes, and complications.
For the IH technique, EUS‑AGS was the first choice
at our center which may be safer for antegrade
procedures, with lower risk of bile leakage. The
technique appears to be safe and effective for
salvage after failure of ERCP, but the success rate of
drainage is low compared with EUS‑transluminal biliary
drainage, as it is a relatively difficult procedure.
The drainage of the common bile duct can be achieved
by two different types of stents, plastic stent, and metal
stent. SEMS should become the standard choice for
EUS‑BD. In most studies, there were no differences
in TSR and FSR between the metal and plastic stents.
However, AEs were lower with metal stents. FC and
PC SEMSs are now commercially available for distal
MBO. While FC SEMS can be easily removed at the
time of reintervention, they are theoretically prone to
migration. The migration rate using PC SEMS is lower
than FC stent in our center. Larger prospective and
multicenter studies are needed to compare the outcomes
and complications between FC and PC stent.
During the EUS‑BD approach, 6‑Fr cystotome was
always used to make a fistula at Sun's center. Moreover,
8‑cm or 10‑cm SEMS was always used during the HGS
approach to avoid migration. In addition, 6‑cm SEMSs
were always used during CDS approach.
During the IH approach, segment 2 was always chosen
at Sun's center because of a relatively high success
rate. However, when B2 puncture is made in the cardia
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or the esophageal gastric junction, there is a problem
of bile reflux into the esophagus. Hence, it is more
reasonable for EUS‑AGS to select B2 as the puncture
site.
There are some other arguments on EUS‑BD as well.
First, can EUS‑BD replace ERCP? EUS‑BD can not
only be used for ERCP failure cases but can also
be applied to patients in whom ERCP cannot be
attempted (such as gastric outlet obstruction). Even
some proponents believe that EUS‑BD may replace
ERCP as the preferred treatment for drainage in MBO,
thus avoiding ERCP associated pancreatitis.
There are limited data on the comparison of the clinical
efficacy of EUS‑BD and ERCP with regard to the
treatment of choice. As EUS‑BD is performed under
direct visualization, it has the potential to replace ERCP.
In a multicenter retrospective study, [47] Dhir et al.
compared EUS‑BD and ERCP for the relief of
distal MBO. The conclusion was that the short‑term
outcome of EUS‑BD is comparable to that of ERCP
in patients with malignant distal common bile duct
(CBD) obstruction. In a new prospective randomized
controlled study by Park et al.,[48] the efficacy and safety
of EUS‑BD and ERCP in MBO were compared. Thirty
patients with EH malignant biliary tract obstruction
were enrolled; 15 each in the EUS‑BD and ERCP‑BD
arms. There were no significant differences both in
terms of TSR and clinical success rates; 100% vs.
93% and 93% vs. 100% in ERCP‑BD vs. EUS‑BD,
respectively. Four patients (31%) had tumors in
growth‑caused stent dysfunction in the ERCP‑BD
group, whereas two patients each had food impaction
and stent migration in the EUS‑BD group. This
prospective, randomized controlled study suggested that
EUS‑BD has a similar safety profile as ERCP‑BD.
Second, in some patients with recurrent cholangitis
after EUS‑BD, what should we do? In the study by
Nakai et al., [49] 16 patients with prior BD for MBO
undergoing conversion to EUS‑BD using a temporary
ENBD tube placement were studied. After a median
duration of 6 days, subsequent conversion to EUS‑BD
using a covered metal stent was performed, which was
technically and clinically successful in all 16 patients.
AEs were observed in three patients (19%): one
bleeding, one cholecystitis, and one cholangitis.
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CONCLUSION
Based on the consensus, the majority of endoscopists felt
that EUS‑BD can replace PTBD as a remedial method
after failure of ERCP. Among all EUS‑BD methods,
most endoscopists felt that the RV technique should be
the first choice. Most endoscopists also felt that SEMS
should become the standard choice for EUS‑BD. A 6‑Fr
cystotome is recommended by most endoscopists for
generating a fistula. During the transgastric‑transhepatic
approach, a longer SEMS (8 or 10 cm) is recommended,
while during the transduodenal‑transcholedochal
approach, a 6‑cm SEMS is recommended.
This is the first worldwide survey on the practice
of EUS‑BD for MBO. There are wide variations in
practice; hence, randomized studies are urgently needed
to establish the best approach for the management of
this condition.
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